For everyone else - cash-pay patients, patients in cities without One Medical locations, patients who need a new prescription quickly, and patients whose budgets align better with compounded GLP-1 pricing - the market for alternatives is active and credible
Under standard FDA review timelines, a decision is expected in late 2026
There is a reason for this: for all intents and purposes, Ozempic and Wegovy are the same medication, administered in slightly different doses
Because glutathione is a tripeptide, the digestive process often breaks it back down into its individual amino acids (glycine, cysteine, and glutamine) before it ever reaches your bloodstream
Glutathione is a tripeptide containing -amide bonds and sulfhydryl groups